IPO
AVROBIO, Inc.
We are a clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.
Symbol
AVRO
Price Range
$16.00 - $18.00
Anticipated Date
TBD
Underwriters
MORGAN STANLEY, COWEN, WELLS FARGO SECURITIES, WEDBUSH PACGROW
To view the prospectus for AVROBIO, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277